HPLC of acetyl-L-carnitine in human plasma by derivatization with p-bromophenacyl bromide

被引:5
|
作者
Park, KM
Lee, MK
Park, YH
Woo, JS
Kim, CK
机构
[1] Seoul Natl Univ, Coll Pharm, Natl Res Lab Bioact Delivery Syst, Seoul 151742, South Korea
[2] Hanmi Pharm Co Ltd, Cent Res Inst, Hwasung Gun 445910, Kyonggi Do, South Korea
关键词
D O I
10.1081/JLC-100103393
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
A high performance liquid chromatographic method is developed for the determination of acetyl-L-carnitine (ALC), an endogenous carnitine derivative, in human plasma, e-Carnitine, which is the structural analogue of ALC, was used as an internal standard. The human plasma samples were treated with ninhydrin solution for the removal of amino acids and then extracted with methanol. After solid phase extraction on silica columns, samples were derivatized with p-bromophenacyl bromide in the presence of 18-crown-6. The derivative of ALC was quantified by high-performance liquid chromatography with UV detection at 260 nm. The retention time of ALC and e-carnitine was about 27.5 and 22.3 min, respectively. The limit of quantitation was 0.22 nmol/mL, based on signal to noise ratio of 3. The accuracy deviation of assay was less than 12.86%, and the intra-day and inter-day coefficients of variation (CV, %) were lower than 5.18 and 5.06%, respectively.
引用
收藏
页码:555 / 563
页数:9
相关论文
共 50 条
  • [21] THE DISRUPTION OF BRAIN MICROTUBULES IN-VITRO BY THE PHOSPHOLIPASE INHIBITOR P-BROMOPHENACYL BROMIDE
    HARGREAVES, AJ
    GLAZIER, AP
    FLASKOS, J
    MULLINS, FH
    MCLEAN, WG
    BIOCHEMICAL PHARMACOLOGY, 1994, 47 (07) : 1137 - 1143
  • [22] ACETYL-L-CARNITINE FOR SYMPTOMATIC DIABETIC NEUROPATHY
    QUATRARO, A
    ROCA, P
    DONZELLA, C
    ACAMPORA, R
    MARFELLA, R
    GIUGLIANO, D
    DIABETOLOGIA, 1995, 38 (01) : 123 - 123
  • [23] Acetyl-L-carnitine ineffective in treatment of CIPN
    Granovetter, Michael
    LANCET ONCOLOGY, 2013, 14 (08): : E299 - E299
  • [24] Acetyl-L-carnitine and peripheral neuropathy - Foreword
    Sima, Anders A. F.
    CNS DRUGS, 2007, 21 : 1 - 2
  • [25] The action of acetyl-L-carnitine in dopaminergic neurotransmission
    Cunha, Lidia
    Szigeti, Krisztian
    Mathe, Domokos
    Metello, Luis
    JOURNAL OF NUCLEAR MEDICINE, 2014, 55
  • [26] Acetyl-L-carnitine for patients with hepatic encephalopathy
    Marti-Carvajal, Arturo J.
    Gluud, Christian
    Arevalo-Rodriguez, Ingrid
    Elena Marti-Amarista, Cristina
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2019, (01):
  • [27] Acetyl-L-Carnitine in Neuropathic PainExperimental Data
    Santina Chiechio
    Agata Copani
    Robert W. Gereau
    Ferdinando Nicoletti
    CNS Drugs, 2007, 21 : 31 - 38
  • [28] ENTRY OF ACETYL-L-CARNITINE INTO BIOSYNTHETIC PATHWAYS
    FARRELL, S
    VOGEL, J
    BIEBER, LL
    BIOCHIMICA ET BIOPHYSICA ACTA, 1986, 876 (01) : 175 - 177
  • [29] Acetyl-L-carnitine for the treatment of HIV lipoatrophy
    Day, L
    Shikuma, C
    Gerschenson, M
    CARNITINE: THE SCIENCE BEHIND A CONDITIONALLY ESSENTIAL NUTRIENT, 2004, 1033 : 139 - 146
  • [30] Acetyl-L-Carnitine Improves Cell Bioenergetics
    Cunha, L.
    Bravo, J.
    Costa, P.
    Fernandes, S.
    Oliveira, M.
    Castro, R.
    Metello, L. F.
    Summavielle, T.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2012, 39 : S432 - S433